chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Fever/low grade fever; Nausea; Muscle aches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm right on 27Mar2021 at 10:00 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, graves' disease, hyperparathyroidism, Afib (atrial fibrillation) and penicillin allergy. Concomitant medications included levothyroxine sodium (SYNTHROID), latanoprost (MANUFACTURER UNKNOWN), metoprolol (MANUFACTURER UNKNOWN) and baby aspirin (MANUFACTURER UNKNOWN) had received within 2 weeks of vaccination for an unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. One week after the vaccination, on 03Apr2021 at 10:00, the patient experienced chills, fever/low-grade fever, nausea, muscle aches and fatigue. The next day, the patient still had low-grade fever and fatigue. The patient still felt off for a couple more days. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visits, emergency room/department or urgent care. On 05Apr2021, the patient underwent a PCR test (nasal swab test) and the result was negative. The clinical outcome of the events chills, fever/low-grade fever, nausea, muscle aches and fatigue was recovered on an unknown date in Apr2021.   No follow-up attempts are needed. No further information is expected.
Started running moderate fever, severe stomach cramps, nausea - just started.  Pain severe enough to prevent sleep.
Shortness of breath; Dizzy; Fast heart beat; Pounding heart beat; Slight chest pressure; Fatigue/tiredness; This is a spontaneous report from a contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an intramuscular route of administration in the right arm on 07Oct2021 at 09:00 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. Concomitant medication included metoprolol (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. On 08Oct2021 at 20:00, the patient experienced shortness of breath, dizzy, fast heart beat, pounding heart beat, slight chest pressure and fatigue/tiredness. On the same day at 20:00, the patient underwent heart rate test and the result was fast heartbeat. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shortness of breath, dizzy, fast heartbeat, pounding heart beat, slight chest pressure and fatigue/tiredness was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
He had a pneumococcal vaccine on his right arm on 10/30/2018. He 3-4 hard lumps across his bicep. That evening he had chills. Cold sweats that evening. Fatigue. Arm was swollen. Arm still a little swollen and looks bruised. Arm is better today. Today the muscle aches.
9MAR sl h/a, achey joints, chills, sl swelling @ immun site; 10MAR more swelling @ site, no h/a, no achiness, no fever; 11MAR inc h/a, inc swelling, no fever, sl fuzziness visually; rx Cephalexin; 12MAR inc swelling-spread to elbow
Zostavax injection given on 2/10/2009 in the right arm subcutaneous.  On 2/17/2009 patient presented with extensive erythematous rash extending from injection site in the proximal posterior arm into the axilla.
Covid symptoms started on October 24, 2022 because I stopped wearing my N95 mask on October 21, 2022.
Pt did not respond to Engerix-B vax series; 11JAN92 HBSAB neg; booster dose administered;
Information had been received on 26-MAY-2017 from a lawyer regarding a case in litigation. It was alleged in litigation that a female patient (age unknown) was inoculated with ZOSTAVAX on or about 27-APR-2010 at a pharmacy, as recommended for routine adult health maintenance for the prevention of shingles (dosage and lot#/expiration not reported). The vaccine did not prevent shingles as intended but rather caused the patient to contract a persistent strain of herpes zoster. On or about 14-MAR-2010 (conflicting information as this precedes date of vaccination), patient was treated by a physician for a vesicular outbreak that was diagnosed as severe shingles. Patient was further diagnosed with post herpetic neuralgia, a secondary condition to shingles that involves residual and chronic nerve pain. Patient was prescribed gabapentin for management of her symptoms. As a direct and proximate result of these malfunctions, patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, patient has suffered and will continue to suffer significant medical expenses and pain and suffering and other damages. Additional information has been requested.
Immediately after injection felt suddenly a hot sensation throughout body, heart started pounding rapidly and uncontrollably, especially on left side of chest, entire left arm started tingling and becoming numb down to my fingertips.  I felt like impending doom and windpipe felt like it was starting to close up. I dialed 911 and took two puffs of my inhaler to open up my lungs.
Case previously recorded as MA2009-4202. Initial case report received from a physician via Novartis Pharma on 10 NOV 2009. A 3-year-old female patient was vaccinated with 0.5 mL of S-OIV FLUVIRIN (batch no. 102046P1) i.m., on 05 NOV 2009. MedCom reference no.: NA09-007859.
Person showed up for clinic and stated she was due for her 2nd vaccine.  Didn't double check to see that she was at 17 days or greater.  She received her 2nd vaccine on day 16.  1st Vaccine was done on 8/4/21 and 2nd Vaccine was on 8/20/21.    She had low grade fever on 8/21/21 and fatigue.    Plan in future is to have two people double checking the dates to make sure we don't give to soon and make sure the person produces the card or we verify in the database.
Received a dose of BioThrax vaccine beyond 28 days from the first puncture of the vial; Spontaneous report received on 18APR2021.  Based on the information obtained from the nurse two individual case safety reports 21000046SP and 21000047SP were created and cross-linked in the database.  The nurse reported that the patient "received a dose of BioThrax vaccine beyond 28 days from the first puncture of the vial" (PT: Vaccination error). The patient received BioThrax (anthrax vaccine adsorbed) (dose: 5, lot number: 300070, and expiry date: 26MAY2021) for immunisation. It was reported that a BioThrax vial was opened (first puncture) on 20FEB2021, and the 28-day expiry of the vial from the first puncture was on 20MAR2021. On 06APR2021, this patient received a dose of BioThrax vaccine from the same vial, which was beyond 28 days from the first puncture of the vial but within the expiration date as labelled on the vial. This was series 5 of BioThrax for the patient.   Additionally, it was reported that as per the Centers for Disease Control and Prevention (CDC), multi-dose vials are to be discarded 28 days after ?rst puncture. Moreover, the nurse stated that "our specific training and guidance states BioThrax is to be discarded 28 days from ?rst puncture" but there was no information about recommendation to be discarded after 28 days from the first puncture with the product.  Action taken with BioThrax with respect to the reported event was not applicable. The outcome of the reported event was unknown.  Company Comment: A patient received a dose of BioThrax vaccine beyond 28 days from the first puncture of the vial (vaccination error), and further information on the event is limited. BioThrax Vials are multi-dose vials and should not be used beyond 28 days of fist puncture. The causality of vaccination error is assessed as not applicable to BioThrax due to the nature of the event.; Sender's Comments: A patient received a dose of BioThrax vaccine beyond 28 days from the first puncture of the vial (vaccination error), and further information on the event is limited. BioThrax Vials are multi-dose vials and should not be used beyond 28 days of fist puncture. The causality of vaccination error is assessed as not applicable to BioThrax due to the nature of the event.
Per patient, he began having shoulder pain a couple of days after getting the flu shot.  It got exponentially worse over the next few weeks. The pain did start to taper and then remained the same.  Feels like what he thinks a rotator cuff tear would feel like. Can not lift right arm during abduction or with any weight in hand.  For example must use left arm to raise right arm to turn off a light switch, or it is completely impossible to pull bed covers up using right arm.  Met with PCP (date unknown).  Sees orthopedic surgeon 10.19.22. Unsure of what treatment will be at this point.
Fever x 10 hrs, starting about 24 hrs after receiving vaccine, only other symptom: nausea. No redness, swelling or tenderness at immunization site. No other concurrent illness.
On the first dose she received just a sore arm and mild headache; On the first dose she received just a sore arm and mild headache; This is a spontaneous report received from a contactable consumer (patient). A 69-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, Lot Number: EN6208), dose 1 via an unspecified route of administration, administered in Arm Left on 21Mar2021 16:45 as a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. After the first dose, she received just a sore arm and mild headache, both on an unspecified date in 2021. The outcome of events was unknown.    No follow-up attempts are needed. No further information is expected.
Bruising on my face, it is visibly notable they are so many around and above the eye also; Bruising on my face, it is visibly notable they are so many around and above the eye also; This is a spontaneous report from a contactable consumer (Patient). A 72-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3302), via an unspecified route of administration on 18Jan2021 at single dose for Covid-19 Vaccination.  Medical history included had major concussion in May2020. Concomitant medication included acetylsalicylic acid (BABY ASPIRIN). The patient was noticing some what looks like bruising on her face, it was visibly notable they were so many around and above the eye also on 18Jan2021. The patient was going to put ice on it. The bruising was appearing where she had major concussion in May2020. The patient was breathing ok, didn't have racing heart, didn't have fever nothing on the big one. No lab work done. The outcome of the events was unknown.
Patient described nausea and then developing pain that went down her spin.  She said the pain localized only to the spin and neck.
No additional AE reported; a dose of PROQUAD was administered to the patient last year on 6JUL2021 after experiencing a temperature excursion; This spontaneous report has been received from a medical assistant concerning a female patient of unknown age. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported.  On an unknown date, a temperature excursion occurred for measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) with an unknown maximum temperature and a timeframe longer than 30 minutes. it was unknown if previous temperature excursions occurred.  On 06-JUL-2021, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA) (PROQUAD) 0.5 milliliter, lot # T029104, expiration date 23-FEB-2022 (route of administration and anatomical location were not provided) as prophylaxis (product storage error). No additional events were reported.
On 2/10/01, pt developed a rash (maculo-papular), unspecific, apparently non-pruritic. Afebrile. No other symptoms or signs. Not on medication. On 2/12/01, viral syndrome. (Saw today in older sister; gastroenteritis).
Fever, CoughWheeze, First symptom was sore throat, then runny nose and cough and chest discomfort from it; low grade fever until 2/17/2021. Symptoms better now.
temperature excursion involving multiple lot numbers for GARDASIL 9, MMR II, ROTATEQ, and RECOMBIV AX. Many of the vaccines have been administered to patients; No further AE; This spontaneous report was received from a practice manager and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medication were not reported.  On 26-AUG-2020, the patient was vaccinated with improperly stored dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 1 injection, lot # R021636 was confirmed to be valid with expiration date 12-MAY-2021(exact dose, route of administration, anatomical location were not reported) for prophylaxis. The temperature excursion was below 2 Celsius degrees (C) (1.1 C) for 27 hours and 45 minutes and above 9 C for 1 hour and 15 minutes (29 hours cumulative). The digital data logger was involved. No adverse effects were reported.  This is one of two reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp; devicelotnumber: R021636; expirationdate: 12-MAY-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other;  followupadditionalinfo :Yes; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2010USA001083:
this patient received an incorrect booster dose.  0.5 mL were administered when the booster dose for Moderna is 0.25 mL.
arm pain; This is a spontaneous report from a contactable consumer. A female patient (reporter's mother) of unspecified age (reported as Age: 86; Unit: Unknown) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on 05Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The reporter's mother, received the vaccine and reported only arm pain in Jan2021. The outcome of the event was unknown.  Information on the lot/batch number has been requested.
I woke up with chest pain.  Went to clinic and was told my potassium levels were high and needed to go to the hospital. My EKG and enzyme levels were abnormal was told I was having a heart attack. A catheterization was done and I was told my arteries were clean and there was no heart damage. I suffered a cardiac spasm, which I was told was a stress induced heart attack
Systemic: Dizziness / Lightheadness-Mild, Systemic: feeling like he was going to pass out-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Shakiness-Mild, Additional Details: Laid patient on floor in Pharmacy, legs elevated, fan on, patient never passed out, but was observed for 30 minutes, recovered and feeling fine when he left the store
Information has been received from a registered nurse concerning a 63 year old male who on 09-Nov-2006 was vaccinated SC with a dose of varicella-zoster virus vaccine live (lot#652925/0621F). On 09-Nov-2006, about two hours post vaccination, his scalp began to itch. Over the next few hours, he developed a maculopapular rash that involved his head, body, and extremities. Unspecified medical attention was sought. At the time of the report, the patient was recovering. A product quality complaint was not involved. Additional information has been requested.
Step mother called in states with in 5 minutes of having vaccines child became hyper. Then within 8 hours child "became mean" Step mother reports biting, hitting. Normally happy child. Also c/o site "hurting"
High BP 180/102 at doctors office resulting in prescription for Lisinopril with Hydrochlorothiazide, Vasovagal syncope resulted in loss of consciousness, falling and hitting head on bathtub.
PATIENT SOUGHT EVALUATION WITH PCP ON 2/5/21. PCP STATES THAT PATIENT REPORTS MINOR RASH BEGAN ON 1/31/21 THAT HAS CONTINUED TO WORSEN DAILY. PCP REPORTS THAT PATIENT HAS A RED RAISED BLISTERING RASH OVER MULTIPLE BODY SURFACE AREA THAT RESEMBLES SHINGLES. NO OTHER SYMPTOMS. PCP REPORTS THAT HE PLANS TO TREAT PATIENT WITH STEROIDS.
menstrual cycle started early after 1st dose.   Irregular cycle since vaccine.  Increased acne more cystic type normally have clear skin.  Higher hair shedding May and June.
Diarrhea, vomiting, inconsolable crying; taken to urgent care for physical exam
This child received the varicella vaccine on June 5, 2000.  She was reported by the daycare as having Chicken Pox.
No adverse effects; a patient received a dose ofMMR II on 5/2/2019 after its expiration date.; This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies, previous drug, reactions, allergies, historical drugs or medical history.     On 02-MAY-2019, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) lot # R002930, expiration date on 31-JAN-2019 (strength, dose, frequency, route of administration, anatomical location, and indication were not reported).   No adverse effects were reported.
At 2 am on 1/9/2021 I woke up with a 102 fever, chills, and body aches. After taking some Tylenol and finally getting some sleep I woke up around 11 am 1/9/2021  during the whole day I have body aches and fever   Saturday 1/9/2021 night I continued to have fever  Sunday 1/10/2021 morning I woke up extremely nauseous   that subsided about mid day and then sunday had low grade fever again Monday 1/11/2021 I still have some body ache and fatigue
10/19/21 EMS called to pt's house because she was unresponsive; has been SOB; pt intubated; hypotensive; vasopressors given; recently diagnosed positive for COVID (10/10/21); breathing has gotten worse since then; admitted to hospital; GI bleed; pt was made DNR by family and transitioned to comfort measures; extubated and she passed away in the hospital
Patient developed new onset headache four days following vaccination, headache progressively worsened over several weeks, eventually she was diagnosed with probable temporal arteritis due to elevated ESR and CRP, and response to prednisone
Arm Killing Her; Excruciating Pain; Couldn't Move Arm; Couldn't Sleep; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm Killing Her), PAIN (Excruciating Pain), LIMB DISCOMFORT (Couldn't Move Arm) and INSOMNIA (Couldn't Sleep) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN IN EXTREMITY (Arm Killing Her), PAIN (Excruciating Pain), LIMB DISCOMFORT (Couldn't Move Arm) and INSOMNIA (Couldn't Sleep). On 14-Feb-2021, PAIN IN EXTREMITY (Arm Killing Her), PAIN (Excruciating Pain), LIMB DISCOMFORT (Couldn't Move Arm) and INSOMNIA (Couldn't Sleep) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant medications not provided.Treatment included Tylenol.   Most recent FOLLOW-UP information incorporated above includes: On 26-Apr-2021: Non significant follow-up appended
developed, "strangulation" feeling in throat, thought initially was her "asthma" until it was "worst attack ever"
This spontaneous report was received from a licensed practical nurse (L.P.N) regarding a patient of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not reported. On an unknown date, the patient was vaccinated with PEDVAXHIB injection, intramuscularly, lot # L035880, expiration date: 11-AUG-2016 (dose and anatomical location of administration were not reported), which was improperly stored at 34.5 F for 10 hours. There was no previous temperature excursion. The temperature excursion was detected by a digital data logger. No adverse effects were reported and no product quality complaint was involved. Additional information has been requested.
Sudden onset back and hip pain Insomnia Diabetes # climbing, harder than usual to regulate.
Information has been received from a physician and a medical assistant concerning a 79 year old female with hypertension and a history of psoriasis, polio, and cataracts and no prior history of respiratory problems who in the morning of 01-APR-2007 was vaccinated SC (also reported as IM) with a 0.65 ml dose of Zostavax (lot # 652936/0981F). The next morning, on 11-APR-2007, she started getting flu-like symptoms. By noon, she started having more severe symptoms, to the extent that she started having a choking feeling. She developed respiratory problems and was admitted to the hospital. She spent one night (24 hours) in the hospital and was found to have had an allergic reaction to Zostavax and a throat spasm. She was given antihistaminic and steroids. She was discharged the following morning and was recovered and was "completely fine". The physician felt that the patient's experiences were related to therapy with Zostavax. Additional information has been requested.
I woke up with a bad sore throat, running nose, sinus congestion, mostly dry cough, and difficulty breathing. My blood levels went down to 90 and that?s when I call the doctor. When I went into the doctor, they checked my lungs and did a chest X-ray, which was fine. It took about a week before my blood levels went back to normal. I was feeling bad for a couple of weeks. I still have a dry cough in the evenings.
Patient developed Acute Promyelocytic Leukemia several months after second vaccination.  Unclear correlation but patient requests submitting this to VAERS.
Lump size of a quarter in leg - right. No facial swelling, difficulty breathing or swallowing. No fever or redness at site. Warm compress applied. TYLENOL for pain.
severe h/a, screaming uncontrollably w/in 1/2 hr twin sibling had no rxn; c/o neck pain & had fever & irritability for 2 days;
Arrived at pharmacy for 1:15 PM vaccine appointment. 10 minutes after vaccine injection, I could not swallow. Throat started to close and feel tight like I could not breathe. Tongue swelled and could not feel tongue while biting down. Chest compression on center chest. Around 1:30 PM I told sister to get a nurse and the nurse said due to my allergic reaction I needed to do the EpiPen.  She administered properly in my thigh. About 1:35 PM, symptoms started to go away. Stayed until 1:45 PM and when I left I told the nurse I was leaving. Took 2 Benadryl pills in my car with water.
The next morning felt very dehydrated and a lot of pain on my arm and on my body. As the day progressed my throat started to hurt bad. The third day I lost my voice. I went to the urgent care and they said I had inflammation on my throat that was the only visual symptom they could see on my body, everything else looked normal.  They did a strep test but it came back normal. My voice returned after three days but I had issues with my throat for seven days total.